Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.29
+4.49 (5.11%)
Mar 4, 2026, 2:20 PM EST - Market open

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,5694,0991,9911,379709488
Market Cap Growth
131.83%105.94%44.32%94.55%45.34%-6.17%
Enterprise Value
5,3894,0332,0261,401559.42333.87
Last Close Price
92.2978.9941.3529.5219.5015.95
PE Ratio
--168.06-22.35-7.38-4.85-5.76
PS Ratio
10.467.865.917.409.2025.49
PB Ratio
14.4813.038.825.554.994.06
P/TBV Ratio
14.7212.608.714.854.674.02
P/FCF Ratio
99.3874.71213.30-19.41-5.89-3.67
P/OCF Ratio
97.6873.43192.79-19.44-5.90-3.67
EV/Sales Ratio
10.347.746.017.527.2617.45
EV/EBITDA Ratio
2556.551913.32-31.67-14.25-4.37-1.93
EV/EBIT Ratio
--182.20-23.13-12.84-4.26-1.93
EV/FCF Ratio
98.2173.50217.13-19.72-4.65-2.51
Debt / Equity Ratio
1.011.011.401.240.020.02
Debt / EBITDA Ratio
150.53150.53-4.94-3.13-0.02-0.01
Debt / FCF Ratio
5.785.7833.87-4.34-0.02-0.02
Net Debt / Equity Ratio
-0.21-0.210.160.09-1.05-1.28
Net Debt / EBITDA Ratio
-31.32-31.32-0.56-0.221.170.89
Net Debt / FCF Ratio
-1.20-1.203.83-0.311.241.16
Asset Turnover
0.690.690.510.370.240.07
Inventory Turnover
4.244.243.653.373.502.52
Quick Ratio
2.462.462.834.072.713.75
Current Ratio
2.672.673.104.452.943.91
Return on Equity (ROE)
-8.65%-8.65%-37.08%-83.65%-103.46%-57.47%
Return on Assets (ROA)
-3.19%-3.19%-13.46%-21.97%-38.70%-64.79%
Return on Invested Capital (ROIC)
-9.33%-9.33%-32.94%-53.21%-105.88%-382.54%
Return on Capital Employed (ROCE)
-3.75%-3.75%-15.87%-25.75%-48.58%-73.10%
Earnings Yield
-0.43%-0.60%-4.47%-13.55%-20.62%-17.37%
FCF Yield
1.01%1.34%0.47%-5.15%-16.98%-27.22%
Buyback Yield / Dilution
-0.98%-0.98%-0.89%-16.47%-16.17%-1.85%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q